Noncolonic cancer stem cells in bone marrow of colorectal cancer patients

Colorectal Disease

Volumn 12, Issue 3, 2010, Pages 206-212

  Altomare, D F ^a   Guanti, G ^b   Hoch, J ^b   Vician, M ^c   Krivokapic, Z ^d   Bergamaschi, R ^e,f  

^a Forde Health System   (Norway)

^b UNIVERSITY OF BARI   (Italy)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Physics and Informatics   (Slovakia)

^e CLINICAL CENTER OF SERBIA   (Serbia)

^f UNIVERSITY OF BERGEN   (Norway)

Author keywords

Anti human epithelial antigen antibody; Bone marrow; Colorectal cancer; Immunobeads; Liver metastases; Noncolonic cancer stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; CYTOKERATIN 20 ANTIBODY; CYTOKERATIN ANTIBODY; DNA; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL COUNT; CELL ISOLATION; COLORECTAL CANCER; FOLLOW UP; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; COLONIC NEOPLASMS; GENES, APC; GENES, P53; HUMANS; LIVER NEOPLASMS; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STEM CELLS; SURVIVAL ANALYSIS;

EID: 77954354938     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01776.x     Document Type: Article

References (33)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005, 365:153-65.
2. Bosch B, Guller U, Schnider A, Maurer R, Harder F, Metzger U, Marti WR. Perioperative detection of disseminated tumor cells in an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003, 90:882-8.
3. Isaka N, Nozue M, Doy M, Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999, 5:2065-8.
4. Molnar B, Ladanyi A, Tanko L, Sreter L, Tulassay Z. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2001, 7:4080-5.
5. O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F. Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 1997, 40:512-5.
6. Diel IJ, Kaufmann M, Costa SD. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996, 88:1652-64.
7. Pantel K, Izbicki J, Passlick B. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 1996, 347:649-53.
8. Oberneder R, Kriegmair M, Pantel K, Staudte A, Hofstetter A, Riethmuller G. Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors. J Urol 1994, 151:413A.
9. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 1992, 340:685-9.
10. Hermanek P, Hutter RVP, Sobin LH, Wittekind C. Classification of isolated tumor cells and micrometastases. Cancer 1999, 86:2668-73.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual 1989, 2nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
12. Yamashita K, Yoshida T, Shinoda H, Okayasu I. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections. Arch Pathol Lab Med 2001, 125:347-52.
13. Miyoshi Y, Nagase H, Ando H. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992, 1:229-33.
14. Stella A, Lonoce A, Resta N. Familial adenomatous polyposis: identification of a new frameshift mutation of the APC gene in an Italian family. Biochem Biophys Res Comm 1992, 184:1357-63.
15. Boland CR, Thibodeau SN, Hamilton SR. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-57.
16. Montera M, Resta N, Simone C. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients. J Med Genet 2000, 37:E7.
17. Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998, 16:557-66.
18. Bjørnland K, Flatmark K, Mala T. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer. J Surg Oncol 2003, 82:224-7.
19. Iovchev I, Trifonov D, Popkharitov A, Khadzhipetkov F, Nikolov S. Micrometastases in patients with colorectal cancer: markers for metastatic potential or proofs for residual disease. Khirurgiia (Sofiia) 2004, 60:18-21.
20. O'Connor OJ, Cahill RA, Kirwan WO, Redmond HP. The impact of bone marrow micrometastases on metastatic disease-free survival in patients with colorectal carcinoma. Colorectal Dis 2005, 7:406-9.
21. Litle VR, Warren RS, Moore D, Pallavicini MG. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer 1997, 79:1664-70.
22. Soeth E, Röder C, Juhl H, Krüger U, Kremer B, Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996, 69:278-82.
23. Shetye JD, Liljefors ML, Emdin SO. Spectrum of cytokeratin-positive cells in the bone marrows of colorectal carcinoma patients. Anticancer Res 2004, 24:2375-83.
24. Redmond KC, Wang JH, Austin KK. Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? J Clin Oncol 2001, 19:3589-92.
25. Zippelius A, Kufer P, Honold G. Limitations of reverse-transcriptase polymerase chain reaction for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997, 15:2701-8.
26. Weihrauch MR, Skibowski E, Koslowsky TC. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters. J Clin Oncol 2002, 20:4338-43.
27. Flatmark K, Bjørnland K, Johannessen HO. Study Group for Micrometastases in BM in Colorectal Cancer. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. Clin Cancer Res 2002, 8:444-9.
28. Jiang JK, Chen YJ, Lin CH, Yu IT, Lin JK. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization. Genes Chromosomes Cancer 2005, 43:25-36.
29. Braun S, Pantel K. Micrometastatic bone marrow involvement: detection and prognostic significance. Med Oncol 1999, 16:154-65.
30. Werther K, Normark M, Brünner N, Nielsen HJ. Cytokeratin-positive cells in preoperative peripheral blood and bone marrow aspirates of patients with colorectal cancer. Scand J Clin Lab Invest 2002, 62:49-57.
31. Sheehan KM, Cahill RA, McGreal G. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases. Dig Liver Dis 2004, 36:392-7.
32. Ricci-Vitiani L, Lombardi DG, Pilozzi E. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-5.
33. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-10.